Sai Life Sciences
Sai Life Sciences, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in Hyderabad, India. Founded in 1999, the company has established itself as a leading Contract Research and Manufacturing Services (CRAMS) provider, catering to global clients in drug discovery, development, and manufacturing. With a strong presence in key operational regions including North America and Europe, Sai Life Sciences offers a comprehensive range of services, from custom synthesis to formulation development. The company is recognised for its commitment to quality and innovation, which has earned it a solid market position and numerous accolades within the industry. Sai Life Sciences continues to drive advancements in life sciences, making significant contributions to the development of new therapeutics.
DitchCarbon Score
How does Sai Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sai Life Sciences's score of 13 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sai Life Sciences's reported carbon emissions
In 2023, Sai Life Sciences reported total carbon emissions of approximately 31,000,800 kg CO2e, comprising 12,610,200 kg CO2e from Scope 1, 17,536,600 kg CO2e from Scope 2, and a negative Scope 3 total of -4,050,000 kg CO2e. This negative figure indicates a reduction in emissions from upstream and downstream activities, which is a notable achievement. Over the years, Sai Life Sciences has shown fluctuations in emissions, with 2020 recording the highest total emissions at approximately 46,000,000 kg CO2e. The company has committed to near-term reduction targets, although it has not set a net-zero commitment as of now. Their emissions data reflects a proactive approach to managing carbon footprints within the pharmaceuticals, biotechnology, and life sciences sector. The company has disclosed emissions across all three scopes, demonstrating transparency in its climate impact. Sai Life Sciences continues to work towards reducing its carbon emissions, aligning with industry standards and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 338,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 20,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 10,000,000 | 0,000,000 | 0,000,000 | - | -0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sai Life Sciences is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
